Dr. Vittorio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
430 East 34th Street
New York, NY 10016Phone+1 212-263-5940Fax+1 212-263-5417
Summary
- Dr. Jennifer Vittorio is a Pediatric Gastroenterologist based in New York, NY, with subspecialties in Pediatric Hepatology and Liver Transplantation. She completed her residencies and fellowships at Georgetown University School of Medicine and New York Presbyterian Hospital. Her experience and clinical interests include neonatal jaundice, pediatric transplant hepatology, cholestasis, care transitions, and acute liver failure. She has seen employment at Hassenfeld Children’s Hospital at NYU Langone, NYU Langone Health, and Columbia University Irving Medical Center. In addition to her clinical work, she has published several research articles in reputable journals and has participated in several clinical trials. Her work has been recognized with awards from Castle Connolly and New York Times Magazine.
Education & Training
- New York Presbyterian HospitalFellowship, Pediatric Transplant Hepatology, 2013 - 2014
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Gastroenterology, 2010 - 2013
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine/Pediatrics, 2006 - 2010
- Georgetown University School of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2010 - 2025
- DC State Medical License 2006 - 2010
- VA State Medical License 2006 - 2010
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
- American Board of Pediatrics Pediatric Transplant Hepatology
Awards, Honors, & Recognition
- Castle Connolly’s Exceptional Women in Medicine 2019
- Top Doctors Rising Star New York Times Magazine, 2015-2017
Clinical Trials
- A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) Start of enrollment: 2019 Jul 09
- Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD) Start of enrollment: 2020 Jul 08
- Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai Start of enrollment: 2021 Jul 08
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsEnteric serotonin and oxytocin: endogenous regulation of severity in a murine model of necrotizing enterocolitis.Kara Gross Margolis, Jennifer Vittorio, Maria Talavera, Karen Gluck, Zhishan Li
American Journal of Physiology. Gastrointestinal and Liver Physiology. 2017-11-01 - 8 citationsInterim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis.Richard J Thompson, Reha Artan, Ulrich Baumann, Pier Luigi Calvo, Piotr Czubkowski
JHEP Reports. 2023-08-01 - 45 citationsDiagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position st...Kris M. Mahadeo, Rajinder P.S. Bajwa, Hisham Abdel-Azim, Leslie Lehmann, Christine Duncan
The Lancet. Haematology. 2020-01-01
Press Mentions
- Measles Devastates Families, Challenges DoctorsOctober 17th, 2019
Professional Memberships
- American Association for the Study of Liver Disease (AASLD)Member
- North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)Member
- Studies of Pediatric Liver Transplantation (SPLIT)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: